Xuefang Cao

MD, PhD
Immunology

About Xuefang Cao

Positions

Roswell Park Comprehensive Cancer Center

  • Assistant Member
  • Department of Immunology
Molecule In Donor Cells May Be Key to Better Outcomes for Transplant Patients

Featured on Cancer Talk

Molecule In Donor Cells May Be Key to Better Outcomes for Transplant Patients

Publications

  • Cai SF, Cao X, Hassan A, Fehniger TA, Ley TJ. Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. Blood. 2010 Mar 4;115(9):1669-77. doi: 10.1182/blood-2009-07-233676. Epub 2009 Nov 13. PMID: 19965675; PMCID: PMC2832813.
  • Cao X. Regulatory T cells and immune tolerance to tumors. Immunol Res. 2010 Mar;46(1-3):79-93. doi: 10.1007/s12026-009-8124-7. PMID: 19763889.
  • Cao X, Leonard K, Collins LI, Cai SF, Mayer JC, Payton JE, Walter MJ, Piwnica-Worms D, Schreiber RD, Ley TJ. Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance. Cancer Res. 2009 Nov 15;69(22):8700-9. doi: 10.1158/0008-5472.CAN-09-1145. Epub 2009 Oct 20. PMID: 19843867; PMCID: PMC2783758.
  • Cao XF, Leonard K. IL-12 Enhances Tumor Immunity Via Differential Effects On Regulatory T Cells and Cytotoxic Lymphocytes. Blood. 2009 Nov;114(22):1656-1656. doi: 10.1182/blood.V114.22.1656.1656.